Meet Our Providers

Wenqing Zhang, M.D.

Specialties
Breast, CLL / HCL, CML / Myelofibrosis / Pvera
Locations
Dixon, Peoria
Board Certifications:
Board Certified in Hematology, Oncology and Internal Medicine
Staff Education:
I graduated from Xinxiang Medical University in 1988, and became an internist working in The First Affiliated Hospital of Xinxiang Medical University in China. I was honored the MD/PhD degree from Beijing Medical University/Beijing Institute for Cancer Research, and practiced medical oncology at Beijing Cancer Hospital, one of the top cancer hospitals in China till 1998.
I completed internal medicine residency training at Albert Einstein College of Medicine/Bronx Lebanon Hospital Center in New York in 2007, practiced internal medicine as a hospitalist in St. Paul, MN in 2007. I finished my hematology/oncology fellowship training at James Graham Brown Cancer Center in Louisville during 2008-2011.
Work History:
I have been practicing hematology and oncology in Carle Cancer Center in Urbana, Illinois, and Thompson Cancer Survival Center in Knoxville, TN between 2011 -2019. I joined Illinois CancerCare in 2019, practicing hematology and Oncology, and participating clinical trials as well.
When did you join Illinois CancerCare?
2019
Hobbies / Interests:
I like traveling, hiking in the mountains, or jogging on the beach. I have been enjoying playing ping-pong and practicing Taichi daily. I also like to be part of the community, participating in the patient care related community events.
What medical change has impacted the field of cancer the most since you began practicing medicine?
Immunotherapy and target therapy have impacted the cancer treatment the most in the past 8-10 years. It has significantly improved certain cancers long term survival with less side effects than traditional chemotherapy, and eventually, we might change cancer into a chronic disease because of the immunotherapy.
Why did you choose your field?
Oncology and hematology is the most challenging subspecialty that involving every single disease system. It’s a fast-changing field in the theory of disease development and progression, new medicine development, new treatment strategy and new cutting edge technology. I like the long term relation with my patient and their family.
Why did you choose Illinois to practice when you could have gone anywhere in the country?
I chose Illinois CancerCare because it’s a well-established, patient care –centered oncology group. ILCC not only provides the sate-of-art treatments for our patients, but also offers clinical trials in different disease category so that our patients have more choose in their care.
Do you have any advice to give patients after they have been diagnosed with cancer?
YOU are not alone, we, my team will fight against the cancer with you. You need know your cancer! I will spend more time explaining the diagnosis, treatment options, side effects, and prognosis. The patient and family always are part of care team and care decision makers. The care team involves multidisciplinary doctors, registered nurses, the social worker, a nutritionist, and, most important, the patient and family. Every patient is different, providing personalized care to my patient is the key in my practice.